-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Initiates Coverage On City Therapeutics with Outperform Rating, Announces Price Target of $46

Benzinga·11/10/2026 12:45:03
语音播报
Oppenheimer analyst Joseph Thomas initiates coverage on City Therapeutics (NASDAQ:CTY) with a Outperform rating and announces Price Target of $46.